Ranitidine medicines are being suspended in the EU due to the presence of the nitrosamine impurity, N-nitrosodimethylamine (NDMA).
While a review of safety data by the European Medicines Agency does not show that ranitidine increases the risk of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?